Optimal drug regimens for improving ALP biochemical levels in patients with primary biliary cholangitis refractory to UDCA: a systematic review and Bayesian network meta-analysis.

Syst Rev · 2024 · PMC10823686 · PMID 38287391

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

The combination treatments showed a trend in reducing the levels of ALP more effectively when compared with UDAC monotherapy in patients with UDCA-refractory PBC.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.